DEA Amends Procedures for Controlled Substance Quotas in Crackdown on Diversion
The Drug Enforcement Administration is amending its procedures for setting and applying for production and procurement quotas for schedule I and II controlled substances. The agency’s final rule updates provisions on the information considered by DEA, in particular directing consideration…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
of the extent of diversion of the controlled substance, when it sets and adjusts aggregate and individual production quotas. DEA will also be able to require additional information from applicants for manufacturing and production quotas that may help to detect or prevent diversion, including customer identities and the amounts of the controlled substance sold to each customer. The measures will help DEA address the ongoing opioid addiction crisis, DEA said. The final rule takes effect Aug. 15.